The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Astrone Capital VCC - Arven
AHCL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Anlon Healthcare has informed BSE of a disclosure filed under Regulation 29(1) of the SEBI Takeover Regulations by Astrone Capital VCC - Arven, a Singapore-based Variable Capital Company (fund vehicle). This regulation requires any shareholder who already holds 5% or more of a company to disclose further acquisitions or disposals that cross prescribed percentage slabs (e.g., crossing 5%, 7.5%, 10%, etc.). The filing indicates Astrone Capital has crossed or moved within one of these slabs, but the detailed direction (buy or sell) and exact percentage change are not visible from the headline alone.
Investors should treat this as a routine creeping-acquisition disclosure from a foreign fund holder. Watch for the detailed PDF on BSE to confirm whether this is an additional buying or a trimming of stake, as either outcome can influence short-term sentiment on Anlon Healthcare's stock.